Testing effectiveness (Phase 2)UnknownNCT05299255What this trial is testingUtidelone in Third-line and Above Treatment of Small Cell Lung CancerWho this might be right forSCLC, Extensive Stage Henan Cancer Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00028028What this trial is testingCCI-779 in Treating Patients With Extensive-Stage Small Cell Lung CancerWho this might be right forExtensive Stage Small Cell Lung Cancer National Cancer Institute (NCI) 80
Not applicableStudy completedNCT00900835What this trial is testingPain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung CancerWho this might be right forBreast CancerColorectal CancerFatigue+3 more City of Hope Medical Center 470
Testing effectiveness (Phase 2)UnknownNCT02171325What this trial is testingStudy of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer TreatmentWho this might be right forSmall Cell Lung Cancer Guangdong Association of Clinical Trials 54
Large-scale testing (Phase 3)Study completedNCT04028050What this trial is testingAtezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung CancerWho this might be right forSmall Cell Lung Carcinoma Hoffmann-La Roche 155
Early research (Phase 1)Study completedNCT00045604What this trial is testingImatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerWho this might be right forLung Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07391813What this trial is testingSNB-101 for Treatment of Extensive Stage Small Cell Lung CancerWho this might be right forPatient is Not Suitable for Complete Surgical Resection With a Cytologically or Histologically Confirmed Small Cell Lung Cancer(SCLC) SN BioScience 55
Large-scale testing (Phase 3)Study completedNCT00365105What this trial is testingZoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast CancerWho this might be right forBreast CancerLung CancerMetastatic Cancer+2 more Radiation Therapy Oncology Group 261
Testing effectiveness (Phase 2)Looking for participantsNCT07423585What this trial is testingTarlatamab for the Treatment of Extensive Stage Small-cell Lung CancerWho this might be right forExtensive Stage Lung Small Cell Carcinoma Asrar Alahmadi 39
Testing effectiveness (Phase 2)Study completedNCT03325816What this trial is testingNivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung CancerWho this might be right forSmall Cell Lung CancerSmall Cell Lung Cancer Extensive Stage Georgetown University 9
Early research (Phase 1)Ended earlyNCT00002947What this trial is testingIndium In 111 Pentetreotide in Treating Patients With Refractory CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more Yale University 35
Large-scale testing (Phase 3)Study completedNCT04774380What this trial is testingStudy of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung CancerWho this might be right forExtensive-stage Small Cell Lung Cancer AstraZeneca 152
Large-scale testing (Phase 3)Study completedNCT00320359What this trial is testingTopotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung CancerWho this might be right forLung Cancer, Small Cell GlaxoSmithKline 700
Post-approval studies (Phase 4)Study completedNCT05071703What this trial is testingEvaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world StudyWho this might be right forExtensive-stage Small-cell Lung Cancer Jiangsu Simcere Pharmaceutical Co., Ltd. 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05224141What this trial is testingPembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)Who this might be right forSmall Cell Lung Carcinoma Merck Sharp & Dohme LLC 460
Testing effectiveness (Phase 2)Looking for participantsNCT05924841What this trial is testingBL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung CancerWho this might be right forSmall Cell Lung Cancer Sichuan Baili Pharmaceutical Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT00316186What this trial is testingFirst-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And ParaplatinWho this might be right forLung Cancer, Small Cell GlaxoSmithKline 33
Testing effectiveness (Phase 2)Study completedNCT00403403What this trial is testingBevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)Who this might be right forSmall Cell Lung Cancer Genentech, Inc. 102
Early research (Phase 1)Looking for participantsNCT06807632What this trial is testingValemetostat in Combination With Atezolizumab in People With Lung CancerWho this might be right forExtensive-stage Small-cell Lung Cancer Memorial Sloan Kettering Cancer Center 24
Early research (Phase 1)Study completedNCT00004604What this trial is testingBiological Therapy in Treating Patients With Metastatic CancerWho this might be right forBreast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more Duke University 24